middle.news
Starpharma Advances FDA Pathway and Expands Middle East Market with $20M Cash Buffer
7:03pm on Monday 2nd of June, 2025 AEST
•
Biotechnology
Read Story
Starpharma Advances FDA Pathway and Expands Middle East Market with $20M Cash Buffer
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Positive FDA feedback on DEP® SN38 clinical and regulatory pathway
Potential Fast Track designation and accelerated approval for DEP® SN38
Upcoming VivaGel® BV launches in Saudi Arabia and UAE
Improved Viraleze™ online sales following digital marketing efforts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SPL
OPEN ARTICLE